Back
Akari Therapeutics PLC Stock Price Chart
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.
Sell
45
AKTX
Akari Therapeutics PLC
Last Price:
$1.39
Seasonality Move:
34.94%
7 Day Trial
ALL ACCESS PASS
$
7
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKTX is experiencing selling pressure, which indicates risk of future bearish movement.
Akari Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.32 | Buy |
| 20-day SMA: | 1.32 | Buy |
| 50-day SMA: | 1.29 | Buy |
| 200-day SMA: | 1.78 | Sell |
| 8-day EMA: | 1.33 | Buy |
| 20-day EMA: | 1.32 | Buy |
| 50-day EMA: | 1.29 | Buy |
| 200-day EMA: | 1.68 | Sell |
Akari Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 51.89 | Buy |
| Chaikin Money Flow: | -10467 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.28 - 1.4) | Buy |
| Bollinger Bands (100): | (1.05 - 1.37) | Buy |
Akari Therapeutics PLC Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 1.34 while AKTX 8-day simple moving average is 1.32, which is a Buy signal.
-
The stock price of AKTX is 1.34 while Akari Therapeutics PLC 20-day SMA is 1.32, which makes it a Buy.
-
Akari Therapeutics PLC 50-day simple moving average is 1.29 while AKTX share price is 1.34, making it a Buy technically.
-
AKTX stock price is 1.34 and Akari Therapeutics PLC 200-day simple moving average is 1.78, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Sell
45
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a SellThe current Akari Therapeutics PLC [AKTX] share price is $1.34. The Score for AKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
43.1M
Price in USD:
1.34
Share Volume:
10.5K
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
0.85
Sell
45
Akari Therapeutics PLC (AKTX)
is a Sell
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?The Akari Therapeutics PLC stock price is 1.34 USD today.
-
Will AKTX stock go up or go down?Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Akari Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is overvalued.
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 1.34 while AKTX 8-day exponential moving average is 1.33, which is a Buy signal.
-
The stock price of AKTX is 1.34 while Akari Therapeutics PLC 20-day EMA is 1.32, which makes it a Buy.
-
Akari Therapeutics PLC 50-day exponential moving average is 1.29 while AKTX share price is 1.34, making it a Buy technically.
-
AKTX stock price is 1.34 and Akari Therapeutics PLC 200-day simple moving average is 1.68, creating a Sell signal.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
-
AKTX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Akari Therapeutics PLC is a Buy
-
Akari Therapeutics PLC Relative Strength Index (RSI) is 51.89, which suggest Akari Therapeutics PLC is overbought
-
The Bollinger Bands (25) for Akari Therapeutics PLC is (1.28 - 1.4), which suggest Akari Therapeutics PLC is a Buy
-
The Bollinger Bands (100) for Akari Therapeutics PLC is (1.05 - 1.37), which suggest Akari Therapeutics PLC is a Buy
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.